Part 7/10:
Retro Biosciences aims to add ten more years to human lifespan using multi-faceted approaches like cellular reprogramming, autophagy enhancement, and plasma-inspired therapeutics. Their research has already identified cellular pathways associated with aging and demonstrated positive results in mammals—an encouraging indicator that human therapies may not be far behind.
The company leverages machine learning and automation extensively, illustrating a broader trend of integrating AI with biotech to accelerate discoveries.
Industry Trends: Tech Where It Counts
Altman’s investments align him with a growing movement among tech giants and entrepreneurs:
- Jeff Bezos has backed Alton Labs—focused on cellular rejuvenation.